z-logo
open-access-imgOpen Access
Case Report of Increased Exposure to Antiretrovirals following Sleeve Gastrectomy
Author(s) -
Sarah Israel,
Hila Elinav,
Ram Elazary,
Daniel Porat,
Roni Gibori,
Arik Dahan,
Carmil Azran,
Ehud Horwitz
Publication year - 2020
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.02453-19
Subject(s) - abacavir , sleeve gastrectomy , dolutegravir , medicine , lamivudine , antiretroviral drug , morbidly obese , surgery , gastrectomy , human immunodeficiency virus (hiv) , drug , obesity , weight loss , antiretroviral therapy , viral load , pharmacology , virology , gastric bypass , virus , cancer , hepatitis b virus
Bariatric surgery is increasingly performed in morbidly obese HIV patients. Limited data exist regarding antiretroviral drug exposure after bariatric surgery. We report a case of a morbidly obese HIV patient who underwent sleeve gastrectomy. Abacavir, lamivudine, and dolutegravir therapeutic drug monitoring was performed at several time points pre- and postsurgery. Significantly increased levels were measured, particularly for abacavir, whose levels increased ∼12-fold. Several mechanistic explanations for these findings are discussed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here